<DOC>
	<DOCNO>NCT01097980</DOCNO>
	<brief_summary>The aim study investigate efficacy trazodone treatment selective serotonin reuptake inhibitor ( ) associate sexual dysfunction . The secondary domain assess relationship 5-HT2A polymorphism treatment efficacy .</brief_summary>
	<brief_title>Trazodone SSRI-sexual Dsyfunction</brief_title>
	<detailed_description />
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<criteria>Inclusion criterion : 1 . 2065 year age , 2. receive SSRI treatment four week , 3. minimal dose fluoxetine , paroxetine , citalopram 20 mg/d , minimal dose fluvoxamine sertraline 50 mg/d , minimal dose escitalopram 10mg/d , 4. develop sexual dysfunction base definition Arizona Sexual ExperienceChinese Version . Exclusion criterion : 1. receive antidepressant agent , 2. receive antipsychotic , 3. currently unstable medical condition unstable angina uncontrolled diabetes , 4. serious medical condition affect sexual functioning epilepsy , serious head injury , brain tumor , HIV infection , Parkinson 's disease , dementia , multiple sclerosis , neurological disorder , 5. pregnant plan become pregnant study period , 6. experience psychotic symptom , 7. comorbidity substance abuse , ( 8 ) develop sexual dysfunction receive SSRIs treatment .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>trazodone</keyword>
	<keyword>SSRI</keyword>
	<keyword>sexual dysfunction</keyword>
	<keyword>5-HT2A polymorphism</keyword>
</DOC>